LEIDOS BIOMEDICAL RESEARCH INC
Federal contract award, Leidos, $1,274,388
Key CONT_AWD_75N91020F00034_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 88 days before this system saw it. One version on record.
Cite this row
28305d74b11d08021b1e19273bc871928e98b7f6ebd3a436e7f934b27d8dd90cThe source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.
Versions
| Version | Amount | Change | Occurred | Published | Retrieved | How it arrived | Content hash |
|---|---|---|---|---|---|---|---|
| 1 current | $1,274,388 | first version | September 25, 2020 | June 9, 2026 | 2026-09-05T00:56:12Z | historical sweep | 28305d74b11d |
Archived copy
https://web.archive.org/web/20261017105352/https://www.usaspending.gov/award/CONT_AWD_75N91020F00034_7529_75N91019D00024_7529 captured by this system, October 17, 2026
What the amount is made of
8 recorded actions, so the amount is the award's current total across all of them. 4 of them obligated money. Measured 2026-10-09, when USAspending reported a total obligation of $1,274,388.
| Action date | Modification | Type | Obligated | Description as recorded |
|---|---|---|---|---|
| June 9, 2026 | P00007 | FUNDING ONLY ACTION | −$1,167 | FY26 UDO INITIATIVE - DEVELOP A NONCOMPETITIVE MONOCLONAL ANTI-CD25 |
| December 11, 2025 | P00006 | OTHER ADMINISTRATIVE ACTION | no money | DEVELOP A NONCOMPETITIVE MONOCLONAL ANTI-CD25 |
| September 5, 2025 | P00005 | OTHER ADMINISTRATIVE ACTION | no money | DEVELOP A NONCOMPETITIVE MONOCLONAL ANTI-CD25 |
| November 6, 2024 | P00004 | OTHER ADMINISTRATIVE ACTION | no money | DEVELOP A NONCOMPETITIVE MONOCLONAL ANTI-CD25 |
| June 13, 2022 | P00003 | OTHER ADMINISTRATIVE ACTION | no money | DEVELOP A NONCOMPETITIVE MONOCLONAL ANTI-CD25 |
| September 15, 2021 | P00002 | EXERCISE AN OPTION | +$601,850 | DEVELOP A NONCOMPETITIVE MONOCLONAL ANTI-CD25 |
| March 23, 2021 | P00001 | EXERCISE AN OPTION | +$84,579 | DEVELOP A NONCOMPETITIVE MONOCLONAL ANTI-CD25 |
| September 25, 2020 | base | not on file | +$589,126 | DEVELOP A NONCOMPETITIVE MONOCLONAL ANTI-CD25 |
Last refreshed November 4, 2026 at 2:31 PM UTC.